Higher antimicrobial gene burden in patients with cirrhosis vs. IBD, other diseases

Higher antimicrobial gene burden in patients with cirrhosis vs. IBD, other diseases

Patients with cirrhosis had a higher abundance of beta-lactamase, vancomycin and quinolone genes in their gut microbiota compared with patients with inflammatory bowel disease, chronic kidney disease and diabetes, according to a presentation from Digestive Diseases Week.”What we found is alarming because it means that patients with cirrhosis may have a much higher burden of antibiotic resistance genes in their gut microbiome compared with other chronic diseases, which puts them at a greater risk for developing poor outcomes,” Jasmohan Bajaj, MD, MS, FACG, AGAF, told HealioRead More

Share on facebook
Share on twitter
Share on linkedin